In a new episode of Podnosis, CVS Caremark Senior Vice President and Chief Growth & Client Success Officer James Margiotta breaks down the forces shaping pharmacy benefits as employers face accelerating drug costs, complex specialty therapies and rising expectations for transparency.
With more than three decades across Aetna, CVS Pharmacy and CVS Caremark, Margiotta explains how plan sponsors are now taking a more active, strategic approach to pharmacy benefits—driven by the rapid growth of specialty spending, GLP‑1 utilization and emerging direct‑to‑consumer channels. He highlights the importance of balancing affordability with a seamless member experience, especially as costs rise and treatment pathways become more fragmented.
Margiotta also details how CVS Caremark is creating value by advancing biosimilar adoption, designing pricing models aligned with true net cost, and integrating deeply with provider workflows. He emphasizes that meaningful transparency requires clear insight into pricing dynamics and the full supply chain.
Looking ahead, he points to AI‑enabled automation, digital engagement tools, and integrated medical and pharmacy data as essential to delivering personalized support, improving adherence and preventing costly events. For sponsors, the message is clear: active, year‑over‑year management paired with strategic partnerships will be key to sustaining affordable, high‑quality pharmacy benefits.
The editorial staff had no role in this post's creation.